Magnesium in PDB 5sf5: Crystal Structure of Human Phosphodiesterase 10 in Complex with 2,3- Dimethyl-6-[2-(1-Methyl-4-Phenylimidazol-2-Yl)Ethyl]Imidazo[1,2- B]Pyridazine
Enzymatic activity of Crystal Structure of Human Phosphodiesterase 10 in Complex with 2,3- Dimethyl-6-[2-(1-Methyl-4-Phenylimidazol-2-Yl)Ethyl]Imidazo[1,2- B]Pyridazine
All present enzymatic activity of Crystal Structure of Human Phosphodiesterase 10 in Complex with 2,3- Dimethyl-6-[2-(1-Methyl-4-Phenylimidazol-2-Yl)Ethyl]Imidazo[1,2- B]Pyridazine:
3.1.4.17;
Protein crystallography data
The structure of Crystal Structure of Human Phosphodiesterase 10 in Complex with 2,3- Dimethyl-6-[2-(1-Methyl-4-Phenylimidazol-2-Yl)Ethyl]Imidazo[1,2- B]Pyridazine, PDB code: 5sf5
was solved by
C.Joseph,
K.Groebke-Zbinden,
J.Benz,
D.Schlatter,
M.G.Rudolph,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
43.82 /
1.98
|
Space group
|
H 3
|
Cell size a, b, c (Å), α, β, γ (°)
|
135.992,
135.992,
236.077,
90,
90,
120
|
R / Rfree (%)
|
17.8 /
22.3
|
Other elements in 5sf5:
The structure of Crystal Structure of Human Phosphodiesterase 10 in Complex with 2,3- Dimethyl-6-[2-(1-Methyl-4-Phenylimidazol-2-Yl)Ethyl]Imidazo[1,2- B]Pyridazine also contains other interesting chemical elements:
Magnesium Binding Sites:
The binding sites of Magnesium atom in the Crystal Structure of Human Phosphodiesterase 10 in Complex with 2,3- Dimethyl-6-[2-(1-Methyl-4-Phenylimidazol-2-Yl)Ethyl]Imidazo[1,2- B]Pyridazine
(pdb code 5sf5). This binding sites where shown within
5.0 Angstroms radius around Magnesium atom.
In total 4 binding sites of Magnesium where determined in the
Crystal Structure of Human Phosphodiesterase 10 in Complex with 2,3- Dimethyl-6-[2-(1-Methyl-4-Phenylimidazol-2-Yl)Ethyl]Imidazo[1,2- B]Pyridazine, PDB code: 5sf5:
Jump to Magnesium binding site number:
1;
2;
3;
4;
Magnesium binding site 1 out
of 4 in 5sf5
Go back to
Magnesium Binding Sites List in 5sf5
Magnesium binding site 1 out
of 4 in the Crystal Structure of Human Phosphodiesterase 10 in Complex with 2,3- Dimethyl-6-[2-(1-Methyl-4-Phenylimidazol-2-Yl)Ethyl]Imidazo[1,2- B]Pyridazine
 Mono view
 Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 1 of Crystal Structure of Human Phosphodiesterase 10 in Complex with 2,3- Dimethyl-6-[2-(1-Methyl-4-Phenylimidazol-2-Yl)Ethyl]Imidazo[1,2- B]Pyridazine within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Mg802
b:26.8
occ:1.00
|
O
|
A:HOH1026
|
1.9
|
26.1
|
1.0
|
OD1
|
A:ASP564
|
2.0
|
26.5
|
1.0
|
O
|
A:HOH931
|
2.0
|
22.9
|
1.0
|
O
|
A:HOH945
|
2.1
|
26.2
|
1.0
|
O
|
A:HOH974
|
2.2
|
26.5
|
1.0
|
O
|
A:HOH935
|
2.2
|
26.0
|
1.0
|
CG
|
A:ASP564
|
3.0
|
32.3
|
1.0
|
OD2
|
A:ASP564
|
3.4
|
29.8
|
1.0
|
ZN
|
A:ZN801
|
3.8
|
32.8
|
1.0
|
O
|
A:HOH987
|
3.9
|
29.1
|
1.0
|
OE2
|
A:GLU592
|
4.0
|
29.1
|
1.0
|
NE2
|
A:HIS595
|
4.1
|
25.3
|
1.0
|
OG1
|
A:THR633
|
4.1
|
28.8
|
1.0
|
O
|
A:HOH1049
|
4.1
|
40.8
|
1.0
|
O
|
A:HOH1015
|
4.3
|
31.5
|
1.0
|
CD2
|
A:HIS563
|
4.3
|
23.8
|
1.0
|
CD2
|
A:HIS595
|
4.4
|
24.1
|
1.0
|
O
|
A:HIS563
|
4.4
|
29.4
|
1.0
|
CB
|
A:ASP564
|
4.4
|
29.6
|
1.0
|
CD2
|
A:HIS567
|
4.4
|
27.3
|
1.0
|
O
|
A:THR633
|
4.5
|
31.2
|
1.0
|
OD2
|
A:ASP674
|
4.5
|
34.6
|
1.0
|
NE2
|
A:HIS567
|
4.6
|
27.3
|
1.0
|
CB
|
A:THR633
|
4.6
|
29.6
|
1.0
|
CD2
|
A:HIS525
|
4.7
|
31.4
|
1.0
|
NE2
|
A:HIS525
|
4.7
|
30.9
|
1.0
|
CA
|
A:ASP564
|
4.8
|
27.9
|
1.0
|
NE2
|
A:HIS563
|
4.8
|
25.7
|
1.0
|
CG
|
A:GLU592
|
4.8
|
27.6
|
1.0
|
CD
|
A:GLU592
|
4.9
|
27.8
|
1.0
|
|
Magnesium binding site 2 out
of 4 in 5sf5
Go back to
Magnesium Binding Sites List in 5sf5
Magnesium binding site 2 out
of 4 in the Crystal Structure of Human Phosphodiesterase 10 in Complex with 2,3- Dimethyl-6-[2-(1-Methyl-4-Phenylimidazol-2-Yl)Ethyl]Imidazo[1,2- B]Pyridazine
 Mono view
 Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 2 of Crystal Structure of Human Phosphodiesterase 10 in Complex with 2,3- Dimethyl-6-[2-(1-Methyl-4-Phenylimidazol-2-Yl)Ethyl]Imidazo[1,2- B]Pyridazine within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Mg802
b:24.5
occ:1.00
|
O
|
B:HOH942
|
2.0
|
28.2
|
1.0
|
O
|
B:HOH969
|
2.0
|
20.6
|
1.0
|
O
|
B:HOH912
|
2.1
|
23.5
|
1.0
|
OD1
|
B:ASP564
|
2.1
|
25.5
|
1.0
|
O
|
B:HOH1015
|
2.1
|
24.0
|
1.0
|
O
|
B:HOH991
|
2.1
|
20.7
|
1.0
|
CG
|
B:ASP564
|
3.1
|
26.3
|
1.0
|
OD2
|
B:ASP564
|
3.4
|
26.3
|
1.0
|
ZN
|
B:ZN801
|
3.8
|
31.6
|
1.0
|
OE2
|
B:GLU592
|
3.9
|
33.5
|
1.0
|
NE2
|
B:HIS595
|
4.0
|
24.6
|
1.0
|
O
|
B:HOH981
|
4.0
|
32.1
|
1.0
|
O
|
B:HOH1061
|
4.0
|
37.6
|
1.0
|
OG1
|
B:THR633
|
4.2
|
25.0
|
1.0
|
CD2
|
B:HIS563
|
4.2
|
24.6
|
1.0
|
O
|
B:HIS563
|
4.3
|
28.8
|
1.0
|
CD2
|
B:HIS567
|
4.3
|
30.1
|
1.0
|
O
|
B:HOH947
|
4.3
|
25.8
|
1.0
|
CD2
|
B:HIS595
|
4.3
|
28.9
|
1.0
|
CB
|
B:ASP564
|
4.4
|
24.6
|
1.0
|
OD2
|
B:ASP674
|
4.5
|
24.8
|
1.0
|
NE2
|
B:HIS567
|
4.5
|
25.3
|
1.0
|
NE2
|
B:HIS563
|
4.6
|
25.4
|
1.0
|
O
|
B:THR633
|
4.6
|
25.9
|
1.0
|
NE2
|
B:HIS525
|
4.6
|
29.8
|
1.0
|
CD2
|
B:HIS525
|
4.6
|
26.8
|
1.0
|
CB
|
B:THR633
|
4.6
|
25.1
|
1.0
|
CG
|
B:GLU592
|
4.7
|
27.5
|
1.0
|
CA
|
B:ASP564
|
4.8
|
27.5
|
1.0
|
CD
|
B:GLU592
|
4.8
|
28.0
|
1.0
|
|
Magnesium binding site 3 out
of 4 in 5sf5
Go back to
Magnesium Binding Sites List in 5sf5
Magnesium binding site 3 out
of 4 in the Crystal Structure of Human Phosphodiesterase 10 in Complex with 2,3- Dimethyl-6-[2-(1-Methyl-4-Phenylimidazol-2-Yl)Ethyl]Imidazo[1,2- B]Pyridazine
 Mono view
 Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 3 of Crystal Structure of Human Phosphodiesterase 10 in Complex with 2,3- Dimethyl-6-[2-(1-Methyl-4-Phenylimidazol-2-Yl)Ethyl]Imidazo[1,2- B]Pyridazine within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
C:Mg802
b:29.0
occ:1.00
|
OD1
|
C:ASP564
|
2.0
|
25.5
|
1.0
|
O
|
C:HOH946
|
2.0
|
24.4
|
1.0
|
O
|
C:HOH966
|
2.0
|
26.8
|
1.0
|
O
|
C:HOH985
|
2.1
|
25.8
|
1.0
|
O
|
C:HOH945
|
2.2
|
26.6
|
1.0
|
O
|
C:HOH1024
|
2.2
|
26.0
|
1.0
|
CG
|
C:ASP564
|
3.0
|
24.3
|
1.0
|
OD2
|
C:ASP564
|
3.4
|
24.8
|
1.0
|
ZN
|
C:ZN801
|
3.8
|
32.8
|
1.0
|
OE2
|
C:GLU592
|
4.0
|
29.3
|
1.0
|
O
|
C:HOH968
|
4.0
|
35.5
|
1.0
|
NE2
|
C:HIS595
|
4.1
|
29.0
|
1.0
|
O
|
C:HOH1062
|
4.1
|
42.5
|
1.0
|
CD2
|
C:HIS563
|
4.2
|
27.8
|
1.0
|
OG1
|
C:THR633
|
4.2
|
29.1
|
1.0
|
CD2
|
C:HIS567
|
4.3
|
27.9
|
1.0
|
O
|
C:HIS563
|
4.3
|
26.6
|
1.0
|
CD2
|
C:HIS595
|
4.3
|
26.6
|
1.0
|
O
|
C:HOH971
|
4.4
|
32.6
|
1.0
|
CB
|
C:ASP564
|
4.4
|
23.6
|
1.0
|
OD2
|
C:ASP674
|
4.4
|
33.0
|
1.0
|
O
|
C:THR633
|
4.5
|
29.7
|
1.0
|
NE2
|
C:HIS567
|
4.5
|
29.1
|
1.0
|
NE2
|
C:HIS563
|
4.6
|
27.6
|
1.0
|
CD2
|
C:HIS525
|
4.6
|
29.6
|
1.0
|
NE2
|
C:HIS525
|
4.7
|
29.8
|
1.0
|
CB
|
C:THR633
|
4.7
|
28.9
|
1.0
|
CA
|
C:ASP564
|
4.7
|
27.4
|
1.0
|
CG
|
C:GLU592
|
4.9
|
29.5
|
1.0
|
CD
|
C:GLU592
|
4.9
|
27.1
|
1.0
|
|
Magnesium binding site 4 out
of 4 in 5sf5
Go back to
Magnesium Binding Sites List in 5sf5
Magnesium binding site 4 out
of 4 in the Crystal Structure of Human Phosphodiesterase 10 in Complex with 2,3- Dimethyl-6-[2-(1-Methyl-4-Phenylimidazol-2-Yl)Ethyl]Imidazo[1,2- B]Pyridazine
 Mono view
 Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 4 of Crystal Structure of Human Phosphodiesterase 10 in Complex with 2,3- Dimethyl-6-[2-(1-Methyl-4-Phenylimidazol-2-Yl)Ethyl]Imidazo[1,2- B]Pyridazine within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
D:Mg802
b:37.8
occ:1.00
|
O
|
D:HOH953
|
2.0
|
29.6
|
1.0
|
O
|
D:HOH967
|
2.1
|
30.4
|
1.0
|
O
|
D:HOH905
|
2.1
|
36.9
|
1.0
|
OD1
|
D:ASP564
|
2.1
|
37.2
|
1.0
|
O
|
D:HOH907
|
2.1
|
31.3
|
1.0
|
O
|
D:HOH976
|
2.2
|
32.7
|
1.0
|
CG
|
D:ASP564
|
3.1
|
34.2
|
1.0
|
OD2
|
D:ASP564
|
3.5
|
38.9
|
1.0
|
ZN
|
D:ZN801
|
3.8
|
39.1
|
1.0
|
O
|
D:HOH982
|
3.8
|
33.6
|
1.0
|
OE2
|
D:GLU592
|
4.0
|
37.1
|
1.0
|
NE2
|
D:HIS595
|
4.0
|
37.5
|
1.0
|
OG1
|
D:THR633
|
4.1
|
34.9
|
1.0
|
O
|
D:HOH987
|
4.1
|
39.7
|
1.0
|
CD2
|
D:HIS595
|
4.3
|
37.2
|
1.0
|
CD2
|
D:HIS563
|
4.3
|
27.6
|
1.0
|
O
|
D:HIS563
|
4.4
|
36.3
|
1.0
|
CD2
|
D:HIS567
|
4.4
|
36.6
|
1.0
|
OD2
|
D:ASP674
|
4.4
|
41.7
|
1.0
|
O
|
D:THR633
|
4.4
|
41.0
|
1.0
|
CB
|
D:ASP564
|
4.5
|
34.5
|
1.0
|
CB
|
D:THR633
|
4.6
|
37.9
|
1.0
|
NE2
|
D:HIS567
|
4.6
|
35.5
|
1.0
|
CD2
|
D:HIS525
|
4.7
|
37.4
|
1.0
|
NE2
|
D:HIS525
|
4.7
|
44.9
|
1.0
|
CA
|
D:ASP564
|
4.8
|
32.6
|
1.0
|
CG
|
D:GLU592
|
4.8
|
39.0
|
1.0
|
CD
|
D:GLU592
|
4.8
|
40.2
|
1.0
|
NE2
|
D:HIS563
|
4.9
|
26.2
|
1.0
|
|
Reference:
A.Tosstorff,
M.G.Rudolph,
J.C.Cole,
M.Reutlinger,
C.Kramer,
H.Schaffhauser,
A.Nilly,
A.Flohr,
B.Kuhn.
A High Quality, Industrial Data Set For Binding Affinity Prediction: Performance Comparison in Different Early Drug Discovery Scenarios. J.Comput.Aided Mol.Des. V. 36 753 2022.
ISSN: ESSN 1573-4951
PubMed: 36153472
DOI: 10.1007/S10822-022-00478-X
Page generated: Mon Sep 30 03:30:12 2024
|